Beyond molecular knockdown, PD-L1 silencing mediated by BMV-VLPs induced functional immunomodulation, increasing CD8+ T-cell–mediated cytotoxicity in melanoma and CMT64 tumor models and enhancing allogeneic T-cell proliferation in dendritic cell–based mixed leukocyte reactions. Here, CD8A is linked to melanoma.